<DOC>
	<DOCNO>NCT02811692</DOCNO>
	<brief_summary>The French CODEX study design national database describe , routine medical practice , functional anatomical response intravitreal Aflibercept injection , large population anti-VGEF-naïve patient present wet Age-related Macular Degeneration ( wAMD ) , Central Retinal Vein Occlusion ( CRVO ) , Branch Retinal Vein Occlusion ( BRVO ) , Diabetic Macular Edema ( DME ) . This national database gather databases French private public ophthalmologic center .</brief_summary>
	<brief_title>Study Collection Aflibercept Data Routine Practice</brief_title>
	<detailed_description>The retrospective data gather first injection Aflibercept indication macular edema follow Branch Retinal Vein Occlusion ( BRVO ) directly physician . For patient , first injection date Aflibercept define index date . Electronic file ophthalmologist , contain patient medical record , periodically transmit accord milestone study maximum 4 transfer ( Q2 2016 first transfer every 9 month thereafter ) . As electronic transfer independent patient ' data anonymized physician transfer , data comparison possible four electronic file transfer plan study period .</detailed_description>
	<mesh_term>Eye Diseases</mesh_term>
	<criteria>Aged ≥18 year old AntiVEGF ( Vascular Endothelial Growth Factor ) treatment naïve Intravitreal ( IVT ) aflibercept injection treatment follow recommendation make within EYLEA Summary Product Characteristics Diagnosed wAMD ( wet Agerelated Macular Degeneration ) , macular edema follow CRVO ( Central Retinal Vein Occlusion ) , macular edema follow BRVO ( Branch Retinal Vein Occlusion ) , DME ( Diabetic Macular Edema ) . Who contraindication list EYLEA Summary Product characteristic Participating investigational program intervention outside routine clinical practice .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Database</keyword>
	<keyword>Diabetic Macular Edema ( DME )</keyword>
	<keyword>Wet Age-related Macular Degeneration ( wAMD )</keyword>
	<keyword>Retinal Diseases</keyword>
	<keyword>Optic Nerve Diseases</keyword>
	<keyword>Corneal Diseases</keyword>
	<keyword>Vision Disorders</keyword>
</DOC>